Advertisement Galapagos extends agreement with NIH - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Galapagos extends agreement with NIH

Galapagos has announced that the US National Institutes of Health have extended their agreement with the company's service division BioFocus DPI for the operation of the Molecular Libraries Small Molecule Repository until December 2010.

According to the terms of this agreement, Galapagos will receive more than $9 million over the course of the two year extension.

BioFocus DPI runs a compound management facility for a number of industrial and US government customers out of its Compound Focus subsidiary in South San Francisco.

Home to the Molecular Libraries Small Molecule Repository since 2004, this facility acquires and stores compounds under the contract with National Institutes of Health (NIH) and distributes these compounds for high-throughput biological screening throughout the NIH’s academic network in the US.